Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on January 27, 2022, disclosing key financial and corporate governance updates. The company announced its financial results for the fourth quarter and full year ended December 31, 2021, through a press release (Exhibit 99.1). This filing also reported the appointment of Andrea B. Smith to its Board of Directors, effective January 26, 2022, increasing the board size to 11 members and assigning her to the Audit and Compliance Committee and the Patient Safety and Quality of Care Committee. Ms. Smith's appointment is a standard board refreshment and does not involve any related-party transactions requiring disclosure. Further investor-focused announcements include a significant expansion of the company's capital return program. HCA's Board of Directors authorized a new share repurchase program for up to $8 billion of its outstanding common stock, demonstrating a strong commitment to returning value to shareholders. Additionally, the Board declared a quarterly cash dividend of $0.56 per share, payable on March 31, 2022, to shareholders of record on March 17, 2022. These actions signal financial strength and confidence in future performance.
Key Highlights
- 1HCA Healthcare announced Q4 and full-year 2021 financial results via press release.
- 2Andrea B. Smith was appointed to the Board of Directors, increasing board size to 11.
- 3Ms. Smith will serve on the Audit and Compliance Committee and Patient Safety and Quality of Care Committee.
- 4Board authorized a new share repurchase program of up to $8 billion.
- 5Quarterly cash dividend declared at $0.56 per share.
- 6Dividend payment date set for March 31, 2022, with a record date of March 17, 2022.
- 7No related-party transactions or special arrangements were disclosed concerning Ms. Smith's appointment.